Jennifer M. Bomberger

Jennifer M. Bomberger

Auto-generated profile, based on publicly available information

Jennifer M. Bomberger

Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HDHaider H. Dar
Haider H. Dar
YTYulia Y. Tyurina
Yulia Y. Tyurina
KMKarolina Mikulska-Ruminska
Karolina Mikulska-Ruminska
ISIndira Shrivastava
Indira Shrivastava
HTHsiu-Chi Ting
Hsiu-Chi Ting
VKValerian E. Kagan
Valerian E. Kagan
Ferroptosis is a death program executed via selective oxidation of arachidonic acid–phosphatidylethanolamines (AA-PE) by 15-lipoxygenases. In mammalian cells and tissues, ferroptosis has been pathogenically associated with brain, kidney, and liver injury/diseases. We discovered that a prokaryotic bacterium, Pseudomonas aeruginosa, that does not contain AA-PE can express lipoxygenase (pLoxA), oxidize host AA-PE to 15-hydroperoxy-AA-PE (15-HOO-AA-PE), and trigger ferroptosis in human bronchial epithelial cells. Induction of ferroptosis by clinical P. aeruginosa isolates from patients with persistent lower respiratory tract infections was dependent on the level and enzymatic activity of pLoxA. Redox phospholipidomics revealed elevated levels of oxidized AA-PE in airway tissues from patients with cystic fibrosis (CF) but not with emphysema or CF without P. aeruginosa. We believe that the evolutionarily conserved mechanism of pLoxA-driven ferroptosis may represent a potential therapeutic target against P. aeruginosa–associated diseases such as CF and persistent lower respiratory tract infections.

4 January 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MHMatthew R. Hendricks
Matthew R. Hendricks
LLLauren P. Lashua
Lauren P. Lashua
DFDouglas K. Fischer
Douglas K. Fischer
BFBecca Anne Flitter
Becca Anne Flitter
KEKatherine M. Eichinger
Katherine M. Eichinger
JBJennifer M. Bomberger
Jennifer M. Bomberger
Significance: Pseudomonas aeruginosa is the major respiratory pathogen that promotes disease progression in chronic lung diseases such as cystic fibrosis (CF) and resides in antibiotic-resistant biofilm communities in the lungs of patients. Little is known about host factors that contribute to the development of bacterial biofilms in the lung. We have observed that respiratory virus coinfection and the antiviral immune response aid in the transition of P . aeruginosa to a biofilm mode of growth through inappropriate release of the nutrient iron. Defining molecular mechanisms by which P . aeruginosa biofilms develop in the lung affords a better opportunity to target therapies to eliminate life-threatening infections in CF and in other chronic lung diseases.

20 December 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MKMegan R. Kiedrowski
Megan R. Kiedrowski
JBJennifer M. Bomberger
Jennifer M. Bomberger
A majority of the morbidity and mortality associated with the genetic disease Cystic Fibrosis (CF) is due to lung disease resulting from chronic respiratory infections. The CF airways become chronically colonized with bacteria in childhood, and over time commensal lung microbes are displaced by bacterial pathogens, leading to a decrease in microbial diversity that correlates with declining patient health. Infection with the pathogen Pseudomonas aeruginosa is a major predictor of morbidity and mortality in CF, with CF individuals often becoming chronically colonized with P. aeruginosa in early adulthood and thereafter having an increased risk of hospitalization. Progression of CF respiratory disease is also influenced by infection with respiratory viruses. Children and adults with CF experience frequent respiratory viral infections with respiratory syncytial virus (RSV), rhinovirus, influenza, parainfluenza, and adenovirus, with RSV and influenza infection linked to the greatest decreases in lung function. Along with directly causing severe respiratory symptoms in CF populations, the impact of respiratory virus infections may be more far-reaching, indirectly promoting bacterial persistence and pathogenesis in the CF respiratory tract. Acquisition of P. aeruginosa in CF patients correlates with seasonal respiratory virus infections, and CF patients colonized with P. aeruginosa experience increased severe exacerbations and declines in lung function during respiratory viral co-infection. In light of such observations, efforts to better understand the impact of viral-bacterial co-infections in the CF airways have been a focus of clinical and basic research in recent years. This review summarizes what has been learned about the interactions between viruses and bacteria in the CF upper and lower respiratory tract and how co-infections impact the health of individuals with CF.

9 May 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
GLGina R. Lewin
Gina R. Lewin
AKAnanya Kapur
Ananya Kapur
DCDaniel M. Cornforth
Daniel M. Cornforth
RDRebecca P. Duncan
Rebecca P. Duncan
FDFrances L. Diggle
Frances L. Diggle
MWMarvin Whiteley
Marvin Whiteley
Laboratory models are critical to basic and translational microbiology research. Models serve multiple purposes, from providing tractable systems to study cell biology to allowing the investigation of inaccessible clinical and environmental ecosystems. Although there is a recognized need for improved model systems, there is a gap in rational approaches to accomplish this goal. We recently developed a framework for assessing the accuracy of microbial models by quantifying how closely each gene is expressed in the natural environment and in various models. The accuracy of the model is defined as the percentage of genes that are similarly expressed in the natural environment and the model. Here, we leverage this framework to develop and validate two generalizable approaches for improving model accuracy, and as proof of concept, we apply these approaches to improve models of Pseudomonas aeruginosa infecting the cystic fibrosis (CF) lung. First, we identify two models, an in vitro synthetic CF sputum medium model (SCFM2) and an epithelial cell model, that accurately recapitulate different gene sets. By combining these models, we developed the epithelial cell-SCFM2 model which improves the accuracy of over 500 genes. Second, to improve the accuracy of specific genes, we mined publicly available transcriptome data, which identified zinc limitation as a cue present in the CF lung and absent in SCFM2. Induction of zinc limitation in SCFM2 resulted in accurate expression of 90% of P. aeruginosa genes. These approaches provide generalizable, quantitative frameworks for microbiological model improvement that can be applied to any system of interest.

15 December 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BFBecca Anne Flitter
Becca Anne Flitter
KHKelli L. Hvorecny
Kelli L. Hvorecny
EOEmiko Ono
Emiko Ono
TETaylor Eddens
Taylor Eddens
JYJun Yang
Jun Yang
JBJennifer M. Bomberger
Jennifer M. Bomberger
Significance: Pseudomonas aeruginosapulmonary infections cause prolonged and destructive inflammation for cystic fibrosis patients. Despite vigorous neutrophilic responses,P. aeruginosapersists in a chronic hyperinflammatory environment. We show that theP. aeruginosavirulence factor, cystic fibrosis transmembrane conductance regulator inhibitory factor (Cif), promotes sustained airway inflammation by reducing host pro-resolving lipid mediators. Cif hydrolyzes epithelial-derived 14,15-epoxyeicosatrienoic acid, disrupting transcellular production of the proresolving lipid 15-epi lipoxin A4(15-epi LXA4) by neutrophils. Clinical data from cystic fibrosis patients revealed that Cif abundance correlated with increased inflammation, decreased 15-epi LXA4, and reduced pulmonary function. Our study and the recent identification of Cif homologs inAcinetobacterandBurkholderiaspecies suggest that bacterial epoxide hydrolases represent a novel virulence strategy shared by multiple respiratory pathogens.

24 August 2023 in Membranes
Verified
Journal Article
Open access
PDF file
LCLily Charpentier
Lily Charpentier
EDEmily F. Dolben
Emily F. Dolben
MHMatthew R. Hendricks
Matthew R. Hendricks
DHDeborah A. Hogan
Deborah A. Hogan
JBJennifer M. Bomberger
Jennifer M. Bomberger
BSBruce Stanton
Bruce Stanton
This article reviews the role of outer membrane vesicles (OMVs) in mediating the interaction between Gram-negative bacteria and their human hosts. OMVs are produced by a diverse range of Gram-negative bacteria during infection and play a critical role in facilitating host–pathogen interactions without requiring direct cell-to-cell contact. This article describes the mechanisms by which OMVs are formed and subsequently interact with host cells, leading to the transport of microbial protein virulence factors and short interfering RNAs (sRNA) to their host targets, exerting their immunomodulatory effects by targeting specific host signaling pathways. Specifically, this review highlights mechanisms by which OMVs facilitate chronic infection through epigenetic modification of the host immune response. Finally, this review identifies critical knowledge gaps in the field and offers potential avenues for future OMV research, specifically regarding rigor and reproducibility in OMV isolation and characterization methods.